Three times weekly, Kim Brennan makes the journey from his residence in Blissfield, N.B. to Miramichi.
This 45-minute drive is essential, as he travels to the city for dialysis sessions.
“I cover my fuel expenses, and often I have someone accompany me… especially when I’m not feeling well,” he shared.
Recently, Brennan learned that he may soon be responsible for more than just transportation costs, as he might also have to pay for some of his medications.
Having suffered from kidney disease since his teenage years, Brennan’s condition deteriorated significantly after a COVID-19 infection a few years back. He has been undergoing hemodialysis since May 2024.
This treatment necessitates that Brennan takes various other medications to manage his health effectively.

Kim Brennan, living near Doaktown, makes trips to Miramichi thrice weekly for his dialysis sessions. (Victoria Walton/CBC)
His medications include carvedilol for hypertension, calcium carbonate to counteract phosphorus accumulation, allopurinol to prevent uric acid buildup, Aspirin for heart health, gabapentin for nerve discomfort, pantoprazole for acid reflux, and two kinds of Vitamin D. He even uses a prescription lotion to alleviate the dry skin often caused by dialysis.
However, during a recent appointment in June, he was informed that the process for obtaining his medications would be changing.
“They were inquiring about my drug coverage,” he recounted. “It seemed somewhat negative, hinting that this might lead to additional costs for me.”
Safer for patients
Until now, Brennan’s medications have been provided by the pharmacy at the Dr. Georges-L.-Dumont University Hospital Centre in Moncton.
These are delivered to Miramichi for patients to collect during their dialysis appointments at no cost.
“The pharmacist mentioned that they are transitioning and will no longer supply our medications from George Dumont,” Brennan said.
“They reviewed our medication lists and stated they would now be reaching out to our local pharmacy of choice.”
Brennan indicated that he does not mind picking up the dialysis-related medications from the Shoppers Drug Mart pharmacy he frequents for other prescriptions. However, he is concerned about the potential expenses.
“It’s quite concerning; many of us rely on long-term disability, and it’s challenging to manage when you’re accustomed to earning more,” he stated. “I’m preparing for the added expenses.”
While Brennan is on long-term disability and has Blue Cross insurance through his employer, he still faces a 20 percent copayment plus a $15 fee for each prescription he collects.
“If you have coverage, they will now want to utilize our personal plans, which could be problematic since some individuals have limits on their accounts, and that may cause complications,” he explained.
“I receive seven or eight, maybe nine different prescriptions from the dialysis pharmacy, so those co-pays can accumulate quickly.”
Vitalité Health Network confirmed via email to CBC News that this transition is taking place and will affect 550 patients across its four health zones.

The dialysis clinic in Miramichi, managed by Vitalité Health Network, will no longer directly supply medications to patients. (Victoria Walton/CBC)
The health network asserts that community pharmacies can “more effectively monitor for drug interactions, allergies, duplicate medications, or necessary dose adjustments.”
Horizon Health Network informed CBC News that it implemented a similar change for its dialysis patients in 2023 and 2024. However, Horizon stated that it collaborated with individuals to ensure “patients would not incur out-of-pocket expenses.”
Vitalité also mentioned that those concerned about costs could enroll in the New Brunswick Drug Plan or the New Brunswick Prescription Drug Plan. However, as outlined on the government’s website, these programs have limitations and are not free.
Worried about what’s next
Upon learning about the impending change, Brennan initiated an online petition that has since garnered over 1,300 signatures.
He expressed a desire to advocate for many of his fellow dialysis patients in Miramichi, who are elderly.
“Some individuals have insurance, while others do not,” Brennan noted. “Certain people will need to consult their social workers, which can be a complex process, requiring proof of income and other documentation to access some of these programs.”
Although Brennan understands the rationale behind the focus on patient safety, he feels that the dialysis medications were already being managed with great care.

Kim Brennan states he takes approximately nine medications daily to support his health throughout dialysis treatments. (Victoria Walton/CBC)
“Those pharmacists were specifically trained for the kidney dialysis field, so they were very knowledgeable about drug interactions pertinent to dialysis patients and had easy access to all the necessary specialists,” he commented.
Brennan is also concerned about the implications this change may have for the future of dialysis care and fears that he may need to travel further for treatment one day.
“As they begin to cut back on services like this, it raises questions about what they might attempt to take away next,” he remarked.
For the moment, he hopes the government will reconsider the change, allowing him and his fellow patients to continue their established routines.
“It’s challenging to confront issues like this when you’re dealing with fatigue and cognitive fog and various side effects from dialysis,” he admitted. “Nevertheless, I felt it was crucial to bring this matter to the government’s attention.”

